Specifically, SLC2A1, SLC2A6, SLC2A10, and SLC2A13 were significantly overexpressed, whereas SLC2A3, SLC2A4, SLC2A9, SLC2A11, and SLC2A12 had downregulated expressions in breast tumors compared with those in normal breast epithelium (Figure 1D). The gene discussed is SLC2A12; the disease is breast neoplasm.